Milan, Italy

Carlo Visco

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nerviano Medical Sciences S.r.l.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlo Visco. Retrieved from https://idiyas.com/inventor/carlo-visco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carlo Visco: Innovator in Antitumor and Antineurodegenerative Research

Introduction

Carlo Visco is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical proteins involved in various diseases.

Latest Patents

Carlo Visco holds a patent for "Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents." This patent describes bicyclic pyrazole and isoxazole derivatives of formula (I) and their pharmaceutically acceptable salts. The compounds disclosed in this patent may be useful in therapy for treating diseases mediated by the HSP90 protein, including cancer and neurodegenerative disorders. He has 1 patent to his name.

Career Highlights

Carlo Visco is currently associated with Nerviano Medical Sciences S.r.l., where he continues to advance his research in medicinal chemistry. His work focuses on developing innovative therapeutic agents that can significantly impact patient care.

Collaborations

He collaborates with esteemed colleagues such as Sergio Mantegani and Maria Gabriella Brasca, contributing to a dynamic research environment that fosters innovation.

Conclusion

Carlo Visco's work in developing antitumor and antineurodegenerative agents showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against complex diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…